A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network
- 30 April 2006
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 9 (4), 273-285
- https://doi.org/10.1016/j.ccr.2006.03.014
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damageThe EMBO Journal, 2005
- A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in HumansCell, 2004
- Dynamics in the p53-Mdm2 ubiquitination pathway.Cell Cycle, 2004
- Amplification of Mdmx (or Mdm4) Directly Contributes to Tumor Formation by Inhibiting p53 Tumor Suppressor ActivityMolecular and Cellular Biology, 2004
- Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and ApoptosisScience, 2004
- Cell Type- and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 ResponsesJournal of Biological Chemistry, 2003
- The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cellsOncogene, 2002
- A Role for the Polyproline Domain of p53 in Its Regulation by Mdm2Published by Elsevier BV ,2001
- Comparative study of the p53-mdm2 and p53-MDMX interfacesOncogene, 1999
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992